This project examines the non-medical use of prescription stimulant drugs among Australian university students for cognitive enhancement purposes. It will, for the first time in Australia, comprehensively examine attitudes, prevalence, motivations, and patterns and consequences of use.
Patterns of alcohol and drug use
There has been a recent increase in the prescribing of pharmaceutical opioids to Chronic Non-Cancer Pain (CNCP) patients in Australia which has led to increasing professional and public concern about the use and harms that may be related to such use.
NIDIP was established in the recognition that there was a greater need for the regular dissemination of trends in the epidemiology of drug-related harms in Australia.
There are growing efforts by pharmaceutical companies to develop opioid formulations that are less prone to misuse (particularly injection), dependence and diversion to illicit markets.
This project forms the basis of Lucy Albertella’s PhD. It is a longitudinal study of cannabis use, schizotypy and attentional inhibition in a sample of 14-24 year olds.
Attention Deficit Hyperactivity Disorder (ADHD) is a significant risk factor for the development of substance use disorders (SUD) in adolescence and adulthood, and ADHD complicates the course and treatment of SUD.
This study aimed to provide novel data on Australian fatalities involving steroids.
Alcohol-related harms contribute substantially to the burden of disease in Australia, with a wide range of acute and chronic consequences associated with alcohol consumption.
This project builds on research by Professor Donald Tashkin (University of California) to further extend the message on respiratory cannabis-related harms.